AU2003273843A1 - Use of skin-protecting substances - Google Patents

Use of skin-protecting substances

Info

Publication number
AU2003273843A1
AU2003273843A1 AU2003273843A AU2003273843A AU2003273843A1 AU 2003273843 A1 AU2003273843 A1 AU 2003273843A1 AU 2003273843 A AU2003273843 A AU 2003273843A AU 2003273843 A AU2003273843 A AU 2003273843A AU 2003273843 A1 AU2003273843 A1 AU 2003273843A1
Authority
AU
Australia
Prior art keywords
skin
protecting substances
protecting
substances
zwitterion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273843A
Other versions
AU2003273843A8 (en
Inventor
August Bernd
Thomas Gassenmeier
Rudiger Graf
Roland Kaufmann
Stefan Kippenberger
Michael Kock
Manfred Schubert-Zsilavecz
Dieter Steinhilber
Oliver Werz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Phenion GmbH and Co KG
Original Assignee
Phenion GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phenion GmbH and Co KG filed Critical Phenion GmbH and Co KG
Publication of AU2003273843A1 publication Critical patent/AU2003273843A1/en
Publication of AU2003273843A8 publication Critical patent/AU2003273843A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Abstract

The invention relates to the use of at least one substance which can form a zwitterion and/or the derivatives thereof for protecting the skin.
AU2003273843A 2002-09-17 2003-09-09 Use of skin-protecting substances Abandoned AU2003273843A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10243233A DE10243233A1 (en) 2002-09-17 2002-09-17 Use of substances to protect the skin
DE10243233.3 2002-09-17
PCT/EP2003/009985 WO2004026295A2 (en) 2002-09-17 2003-09-09 Use of skin-protecting substances

Publications (2)

Publication Number Publication Date
AU2003273843A1 true AU2003273843A1 (en) 2004-04-08
AU2003273843A8 AU2003273843A8 (en) 2004-04-08

Family

ID=32009839

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273843A Abandoned AU2003273843A1 (en) 2002-09-17 2003-09-09 Use of skin-protecting substances

Country Status (6)

Country Link
EP (1) EP1539128B1 (en)
AT (1) ATE408404T1 (en)
AU (1) AU2003273843A1 (en)
BR (1) BR0314300A (en)
DE (2) DE10243233A1 (en)
WO (1) WO2004026295A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004009698D1 (en) * 2003-08-05 2007-12-06 Ct De Histoterapia Placentaria COMPOSITION CONTAINING L-PROLINE FOR THE TREATMENT OF VITILIGO &x9; >
US20090017047A1 (en) * 2004-06-11 2009-01-15 Egon Tech Preparation for the Prevention and Treatment of Stress Conditions as Well as Functional and Organic Disorders of the Nervous System and Metabolic Disorders
US7704531B2 (en) 2005-02-18 2010-04-27 Colgate-Palmolive Company Enhanced efficacy aluminum or aluminum-zirconium antiperspirant salt compositions containing calcium salt(s) and betaine
WO2006103056A2 (en) * 2005-03-30 2006-10-05 Gerhard Sauermann Topical product containing betaine for preventing and treating nappy rash
FR2885801B1 (en) * 2005-05-20 2009-01-09 Sothys Paris Soc Par Actions Sa COSMETIC COMPOSITION
DE102005026034A1 (en) * 2005-06-02 2006-12-07 Beiersdorf Ag Cosmetic preparation, useful as cosmetic sticks, comprises lipid phase, creatine hydrate, water-in-oil-emulsifier and water
US7781391B2 (en) 2006-03-17 2010-08-24 Croda, Inc. Amine/amide-functionalized lipophiles
WO2009002913A1 (en) * 2007-06-22 2008-12-31 Avicena Group, Inc. Use of creatine compounds to treat dermatitis
FR2961392A1 (en) * 2010-06-17 2011-12-23 Oreal USE OF AMINO ACID DERIVATIVES AS A TREATMENT AGENT FOR HUMAN PERSPIRATION; NEW COMPOUNDS; COMPOSITIONS CONTAINING THEM
DE102020125874A1 (en) * 2020-10-02 2022-04-07 Dr. Kurt Wolff Gmbh & Co. Kg Hair and skin treatment composition
DE102020125873A1 (en) * 2020-10-02 2022-04-07 Dr. Kurt Wolff Gmbh & Co. Kg Hair and scalp treatment composition
WO2023194567A1 (en) * 2022-04-06 2023-10-12 Dr. Kurt Wolff Gmbh & Co. Kg Oral composition containing dimethylglycine for improving the condition of the hair and scalp
DE102022108329A1 (en) * 2022-04-06 2023-10-12 Dr. Kurt Wolff Gmbh & Co. Kg Composition for treating the skin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066589A (en) * 1975-05-23 1978-01-03 Minnesota Mining And Manufacturing Company Solvent repellent complexes
DE2703964A1 (en) * 1975-07-08 1978-08-03 Walter Dr Schweckendiek Preparations contg. fumaric acid, glycine and opt. phosphate - for internal and external treatment of psoriasis
IE52977B1 (en) * 1981-11-24 1988-04-27 Pascale Ltd Protective composition for users of cyanoacrylate adhesives
GB8713091D0 (en) * 1987-06-04 1987-07-08 Millrine W P Pharmaceutical compositions
HU208072B (en) * 1990-02-28 1993-08-30 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition suitable for preventing and curing autoimmune diseases and skin affections caused by heat and light radiacion
JPH0948720A (en) * 1995-08-03 1997-02-18 Shiseido Co Ltd Skin preparation for external use
US6114337A (en) * 1998-11-27 2000-09-05 Pugliese; Peter T. Zwitteronic-fatty acid compounds having anti-inflammatory properties
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
WO2000037071A1 (en) * 1998-12-21 2000-06-29 Aps Kbus 8 Nr. 4788 Topical treatment of skin disease
DE60018438T2 (en) * 1999-09-15 2006-03-16 Bayer Consumer Care Ag PHARMACEUTICAL AND / OR COSMETIC COMPOSITIONS
WO2003075903A2 (en) * 2002-03-08 2003-09-18 Universiteit Leiden Use proline and its functional equivalentsfor quenching ros and/ or radicals

Also Published As

Publication number Publication date
ATE408404T1 (en) 2008-10-15
WO2004026295A2 (en) 2004-04-01
WO2004026295A9 (en) 2004-09-16
EP1539128B1 (en) 2008-09-17
DE10243233A1 (en) 2004-04-15
WO2004026295A3 (en) 2004-11-11
BR0314300A (en) 2005-07-26
DE50310527D1 (en) 2008-10-30
AU2003273843A8 (en) 2004-04-08
EP1539128A2 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
AU2003257666A1 (en) COMPOUND HAVING TGFss INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
WO2003080582A3 (en) Fredericamycin derivatives
AUPP609198A0 (en) Use of non-peptidyl compounds for the treatment of insulin related ailments
EP1476471A4 (en) Nutraceuticals for the treatment, protection and restoration of connective tissues
AU2003289440A1 (en) Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003295890A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
AU2003211453A1 (en) External compositions for the skin
AU2003273843A1 (en) Use of skin-protecting substances
AU2003289234A1 (en) Skin material for external use and antiprutiric agent for external use and wrinkle-reducing instrument using the same
AU2002368133A1 (en) 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis
AU2003288971A1 (en) Compositions for darkening the skin and/or hair
AU2003264406A1 (en) Drug or cosmetic
PL375627A1 (en) 2-pyrrolidin-2-yl-[1,3,4]-oxadiazole derivatives and the use of the same as antidepressants
AU2003227593A1 (en) New analogs of nitrobenzylthioinosine
AU2003275610A1 (en) Liquid skin protective composition
AU2003203233A1 (en) N-substituted sulfonamide derivatives and preventive or therapeutic drugs for diabetes containing the same
AU2003201892A1 (en) Skin perparation for external use containing purpuricenus temminckii frass as the active ingredient
AU2002361203A1 (en) 3h-naphtho(2,1-b)-pyrane derivatives and the use of the same
AU2003263978A1 (en) 2',3'-dideoxynucleoside analogues for the treatment or prevention of flavivitridae infections
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2004288646A1 (en) Use of lipopeptides for activating T lymphocytes through the skin
AU2003284623A1 (en) Medicinal composition for treating sudden deafness

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase